title: Radotinib in the treatment of chronic phase chronic myeloid leukemia patients.
authors.affiliation: Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey emreeskazan@hotmail.com.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eskazan
authors.affiliation: Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
authors.forename: Teoman
authors.initials: T
authors.lastname: Soysal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors*; D006801:Humans; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D016044:Fusion Proteins, bcr-abl
keywords: chronic myeloid leukemia; imatinib; radotinib; tyrosine kinase inhibitor